Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,172 GBX | -0.60% | -0.75% | +14.83% |
May. 15 | ASTRAZENECA : UBS reiterates its Sell rating | ZD |
May. 14 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Analyst Reco.